Novartis Inks Up-to-$5.7B Second Collaboration with Monte Rosa
Nearly a year after licensing Monte Rosa Therapeutics’ Phase II-bound autoimmune disease candidate MRT-6160, Novartis has agreed to…
Roche Commits $50B to U.S. Manufacturing, R&D as Tariffs Loom
With tariffs looming over biopharma, Roche became the latest industry giant to announce large-scale plans for new U.S.…
10x, Roche, Prognosys Sue Illumina over Spatial and Single-Cell Patents
10x Genomics’ facility at 5500 Stoneridge Mall Road Pleasanton, CA, one of the company’s three sites in the…
Recursion, Roche Unveil Microglia Map of Neuro Disease Targets
Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI)…